Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease

Clinical trial NCT00348140 · COMPLETED

Trial details

NCT number: NCT00348140
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2006-07-12
Primary completion: 2009-03-20
Enrollment: 1468

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.